Neuroreport · 2003 · 137 citations · 16 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurochemistryNeurodegenerationAlzheimer DiseaseMicroglia BiologyNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid-associated NeurotoxicityAmyloid-beta-induced NeurotoxicityIndoleamine 2, 3-Dioxygenase PathwayNeuroinflammation In Alzheimer DiseaseTryptophan MetabolismTryptophan Oxidation
We hypothesized that the tryptophan catabolites produced through the kynurenine pathway (KP), and more particularly the excitotoxin quinolinic acid (QUIN), may play an important role in the pathogenesis of Alzheimer's disease (AD). In this study, we demonstrated that aggregated amyloid peptide A beta 1-42 induced indoleamine 2,3-dioxygenase (IDO) expression and resulted in a significant increase in production of QUIN by human primary macrophages and microglia. In contrast, A beta 1-40 and prion peptide (PrP) 106-126 did not induce any significant increase in QUIN production. These data imply that local QUIN production may be one of the factors involved in the pathogenesis of neuronal damage in AD.
16
Tryptophan degradation and immune activation in Alzheimer's disease
Bernhard Widner, F. Leblhuber, J. Walli et al. · Journal of Neural Transmission · 2000 · 288 citations
Kynurenine metabolism in Alzheimer's disease
Halina Baran, K. A. Jellinger, L. Deecke · Journal of Neural Transmission · 1999 · 237 citations